TY - JOUR
T1 - Focal ischemic injury to the early neonatal rat brain models cognitive and motor deficits with associated histopathological outcomes relevant to human neonatal brain injury
AU - Kagan, Brett J.
AU - Ermine, Charlotte M.
AU - Frausin, Stefano
AU - Parish, Clare L.
AU - Nithianantharajah, Jess
AU - Thompson, Lachlan H.
N1 - Funding Information:
Funding: This work was supported NHMRC project grant 1130734. The Florey Institute of Neuroscience and Mental Health acknowledges the strong support from the Victorian Government and in particular the funding from the Operational Infrastructure Support Grant. C.L.P. is an NHMRC Senior Research Fellow.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/5/1
Y1 - 2021/5/1
N2 - Neonatal arterial ischemic stroke is one of the more severe birth complications. The injury can result in extensive neurological damage and is robustly associated with later diagnoses of cerebral palsy (CP). An important part of efforts to develop new therapies include the on-going refinement and understanding of animal models that capture relevant clinical features of neonatal brain injury leading to CP. The potent vasoconstrictor peptide, Endothelin-1 (ET-1), has previously been utilised in animal models to reduce local blood flow to levels that mimic ischemic stroke. Our previous work in this area has shown that it is an effective and technically simple approach for modelling ischemic injury at very early neonatal ages, resulting in stable deficits in motor function. Here, we aimed to extend this model to also examine the impact on cognitive function. We show that focal delivery of ET-1 to the cortex of Sprague Dawley rats on postnatal day 0 (P0) resulted in impaired learning in a touchscreen-based test of visual discrimination and correlated with important clinical features of CP including damage to large white matter structures.
AB - Neonatal arterial ischemic stroke is one of the more severe birth complications. The injury can result in extensive neurological damage and is robustly associated with later diagnoses of cerebral palsy (CP). An important part of efforts to develop new therapies include the on-going refinement and understanding of animal models that capture relevant clinical features of neonatal brain injury leading to CP. The potent vasoconstrictor peptide, Endothelin-1 (ET-1), has previously been utilised in animal models to reduce local blood flow to levels that mimic ischemic stroke. Our previous work in this area has shown that it is an effective and technically simple approach for modelling ischemic injury at very early neonatal ages, resulting in stable deficits in motor function. Here, we aimed to extend this model to also examine the impact on cognitive function. We show that focal delivery of ET-1 to the cortex of Sprague Dawley rats on postnatal day 0 (P0) resulted in impaired learning in a touchscreen-based test of visual discrimination and correlated with important clinical features of CP including damage to large white matter structures.
KW - Cerebral palsy
KW - Endothelin-1
KW - Neonatal stroke
KW - Pairwise discrimination
KW - Rodent models
KW - Touchscreen testing
KW - White matter injury
UR - http://www.scopus.com/inward/record.url?scp=85105449003&partnerID=8YFLogxK
U2 - 10.3390/ijms22094740
DO - 10.3390/ijms22094740
M3 - Article
C2 - 33947043
AN - SCOPUS:85105449003
SN - 1422-0067
VL - 22
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 9
M1 - 4740
ER -